124 related articles for article (PubMed ID: 18432643)
1. HLA type of EBV-transformed human B cell lines.
Hurley CK; Johnson AH
Curr Protoc Immunol; 2001 May; Appendix 1():Appendix 1G. PubMed ID: 18432643
[TBL] [Abstract][Full Text] [Related]
2. Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.
Creary LE; Guerra SG; Chong W; Brown CJ; Turner TR; Robinson J; Bultitude WP; Mayor NP; Marsh SGE; Saito K; Lam K; Duke JL; Mosbruger TL; Ferriola D; Monos D; Willis A; Askar M; Fischer G; Saw CL; Ragoussis J; Petrek M; Serra-Pagés C; Juan M; Stavropoulos-Giokas C; Dinou A; Ameen R; Al Shemmari S; Spierings E; Gendzekhadze K; Morris GP; Zhang Q; Kashi Z; Hsu S; Gangavarapu S; Mallempati KC; Yamamoto F; Osoegawa K; Vayntrub T; Chang CJ; Hansen JA; Fernández-Viňa MA
Hum Immunol; 2019 Jul; 80(7):449-460. PubMed ID: 30844424
[TBL] [Abstract][Full Text] [Related]
3. CD4+ T cell-induced differentiation of EBV-transformed lymphoblastoid cells is associated with diminished recognition by EBV-specific CD8+ cytotoxic T cells.
Khanolkar A; Fu Z; Underwood LJ; Bondurant KL; Rochford R; Cannon MJ
J Immunol; 2003 Mar; 170(6):3187-94. PubMed ID: 12626577
[TBL] [Abstract][Full Text] [Related]
4. HLA-D typing using Epstein-Barr virus-induced lymphoblastoid cell lines.
Akiyama N; Ohsawa N; Samaru Y; Kusaba R
Jpn J Exp Med; 1982 Apr; 52(2):67-73. PubMed ID: 6288983
[TBL] [Abstract][Full Text] [Related]
5. HLA-A alleles of patients with pyothorax-associated lymphoma: anti-Epstein-Barr virus (EBV) host immune responses during the development of EBV latent antigen-positive lymphomas.
Kanno H; Ohsawa M; Hashimoto M; Iuchi K; Nakajima Y; Aozasa K
Int J Cancer; 1999 Aug; 82(5):630-4. PubMed ID: 10417757
[TBL] [Abstract][Full Text] [Related]
6. The Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) as stimulating cells in mixed lymphocyte culture (MLC).
Wasik M; Matej H; Duś D; Myc A
Arch Immunol Ther Exp (Warsz); 1983; 31(6):879-85. PubMed ID: 6331341
[TBL] [Abstract][Full Text] [Related]
7. HLA-G expression is induced in Epstein-Barr virus-transformed B-cell lines by culture conditions.
Gazit E; Sherf M; Balbin E; Muratov A; Goldstein I; Loewenthal R
Hum Immunol; 2007 Jun; 68(6):463-8. PubMed ID: 17509445
[TBL] [Abstract][Full Text] [Related]
8. Provision of Epstein-Barr virus-transformed B-cell lines in a routine tissue typing laboratory: practicalities and applications.
Bass H; Walters R; Darke C
Eur J Immunogenet; 2004 Apr; 31(2):87-92. PubMed ID: 15086349
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens.
Akiyama N; Ohsawa N; Kusaba R; Inou T; Takada M
Jpn J Exp Med; 1981 Feb; 51(1):1-7. PubMed ID: 6273617
[TBL] [Abstract][Full Text] [Related]
10. Some Epstein-Barr virus-transformed B lymphoblastoid cell lines have an altered structure around the mixed lymphocyte culture-inducing domain on DR molecules.
Nagayoshi T; Morito F; Kaneoka H; Yamaguchi M
Fukuoka Igaku Zasshi; 1986 May; 77(5):287-92. PubMed ID: 3017826
[No Abstract] [Full Text] [Related]
11. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
[TBL] [Abstract][Full Text] [Related]
12. HLA-restricted presentation of WT1 tumor antigen in B-lymphoblastoid cell lines established using a maxi-EBV system.
Kanda T; Ochi T; Fujiwara H; Yasukawa M; Okamoto S; Mineno J; Kuzushima K; Tsurumi T
Cancer Gene Ther; 2012 Aug; 19(8):566-71. PubMed ID: 22722376
[TBL] [Abstract][Full Text] [Related]
13. Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells.
MacArthur GJ; Wilson AD; Birchall MA; Morgan AJ
J Virol; 2007 May; 81(9):4766-75. PubMed ID: 17314172
[TBL] [Abstract][Full Text] [Related]
14. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
Hutchings IA; Tierney RJ; Kelly GL; Stylianou J; Rickinson AB; Bell AI
J Virol; 2006 Nov; 80(21):10700-11. PubMed ID: 16920819
[TBL] [Abstract][Full Text] [Related]
15. Silencing the shutoff protein of Epstein-Barr virus in productively infected B cells points to (innate) targets for immune evasion.
van Gent M; Gram AM; Boer IGJ; Geerdink RJ; Lindenbergh MFS; Lebbink RJ; Wiertz EJ; Ressing ME
J Gen Virol; 2015 Apr; 96(Pt 4):858-865. PubMed ID: 25502648
[TBL] [Abstract][Full Text] [Related]
16. Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus-transformed human lymphoblastoid B-cell lines.
Reitnauer PJ; Brown LR; Hank JA; Sondel PM
Cell Immunol; 1986 Apr; 99(1):196-208. PubMed ID: 3019572
[TBL] [Abstract][Full Text] [Related]
17. Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response.
Sugano M; Conway TF; Kelleher RJ; Sugiyama Y; Chen FA; Bankert RB; Bernstein SH
J Exp Clin Cancer Res; 2001 Jun; 20(2):175-82. PubMed ID: 11484971
[TBL] [Abstract][Full Text] [Related]
18. In vitro induction of HLA-restricted cytotoxic T lymphocytes against autologous Epstein-Barr Virus transformed B lymphoblastoid cell line.
Fukukawa T; Hirano T; Sakaguchi N; Teranishi T; Tsuyuguchi I; Nagao N; Naito N; Yoshimura K; Okubo Y; Tohda H; Oikawa A
J Immunol; 1981 May; 126(5):1697-701. PubMed ID: 6163815
[TBL] [Abstract][Full Text] [Related]
19. The proliferative immune response to autologous Epstein-Barr virus transformed lymphoblastoid cells. II. Studies with HLA class II loss variants demonstrate a role for gene products other than DR and DQ.
Reitnauer PJ; DeMars R; Sondel PM
Hum Immunol; 1986 Jul; 16(3):276-88. PubMed ID: 3013814
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of Epstein-Barr virus (EBV) genes BBRF3, BILF1, and BMRF2 in EBV-transformed lymphoblastoid lines from ataxia-telangiectasia patients.
Becker Y; Tabor E; Asher Y
Leukemia; 1988 Dec; 2(12 Suppl):178S-191S. PubMed ID: 2848995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
